Zhejiang Orient Gene Biotech Co (SHSE:688298) Change In Other Working Capital : ¥0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Zhejiang Orient Gene Biotech Co Change In Other Working Capital?

Zhejiang Orient Gene Biotech Co's Change In Other Working Capital for the quarter that ended in Mar. 2025 was ¥0.0 Mil. It means Zhejiang Orient Gene Biotech Co's Other Working Capital stayed the same from Dec. 2024 to Mar. 2025 .

Zhejiang Orient Gene Biotech Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was ¥-34.0 Mil. It means Zhejiang Orient Gene Biotech Co's Other Working Capital declined by ¥34.0 Mil from Dec. 2023 to Dec. 2024 .

Zhejiang Orient Gene Biotech Co Change In Other Working Capital Historical Data

The historical data trend for Zhejiang Orient Gene Biotech Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Orient Gene Biotech Co Change In Other Working Capital Chart

Zhejiang Orient Gene Biotech Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

1,007.08

904.30

51.55

-1,697.48

-34.00

Zhejiang Orient Gene Biotech Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial															-	-	-	-	-

Zhejiang Orient Gene Biotech Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

Zhejiang Orient Gene Biotech Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Zhejiang Orient Gene Biotech Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Orient Gene Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zhejiang Orient Gene Biotech Co Ltd (SHSE:688298) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

3787 East Section of Yangguang Avenue, Dipu Street, Anji County, Zhejiang Province, Huzhou, CHN, 313300

Website

http://www.orientgene.com

Zhejiang Orient Gene Biotech Co Ltd is engaged in production, research, development and sale of vitro diagnostic products. The company's products include Genetic diagnosis, Colloidal gold rapid diagnostic tests, Dry chemical strips (urinalysis), Bio-liquid diagnostic kits, Clinical test instruments, POCT time-resolved Fluor immunoassay Test kit (TRFI), and Raw materials.

Zhejiang Orient Gene Biotech Co Headlines

No Headlines